IceCure Medical Ltd Statistics
Share Statistics
IceCure Medical Ltd has 54.78M shares outstanding. The number of shares has increased by 8.49% in one year.
| Shares Outstanding | 54.78M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 3.29% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 24.40M |
| Failed to Deliver (FTD) Shares | 243.23K |
| FTD / Avg. Volume | 34.52% |
Short Selling Information
The latest short interest is 282.23K, so 0.57% of the outstanding shares have been sold short.
| Short Interest | 282.23K |
| Short % of Shares Out | 0.57% |
| Short % of Float | 1.28% |
| Short Ratio (days to cover) | 0.46 |
Valuation Ratios
The PE ratio is -3.33 and the forward PE ratio is -2.36.
| PE Ratio | -3.33 |
| Forward PE | -2.36 |
| PS Ratio | 15.12 |
| Forward PS | 7.3 |
| PB Ratio | 4.01 |
| P/FCF Ratio | -3.76 |
| PEG Ratio | n/a |
Enterprise Valuation
IceCure Medical Ltd has an Enterprise Value (EV) of 38.90M.
| EV / Earnings | -2.65 |
| EV / Sales | 12.05 |
| EV / EBITDA | -2.55 |
| EV / EBIT | -2.5 |
| EV / FCF | -2.99 |
Financial Position
The company has a current ratio of 3.66, with a Debt / Equity ratio of 0.
| Current Ratio | 3.66 |
| Quick Ratio | 3.08 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.2% and return on capital (ROIC) is -122.05%.
| Return on Equity (ROE) | -1.2% |
| Return on Assets (ROA) | -0.89% |
| Return on Capital (ROIC) | -122.05% |
| Revenue Per Employee | 45.48K |
| Profits Per Employee | -206.37K |
| Employee Count | 71 |
| Asset Turnover | 0.2 |
| Inventory Turnover | 0.85 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 11.58% in the last 52 weeks. The beta is 2.63, so IceCure Medical Ltd's price volatility has been higher than the market average.
| Beta | 2.63 |
| 52-Week Price Change | 11.58% |
| 50-Day Moving Average | 0.69 |
| 200-Day Moving Average | 0.86 |
| Relative Strength Index (RSI) | 73.99 |
| Average Volume (20 Days) | 704.51K |
Income Statement
In the last 12 months, IceCure Medical Ltd had revenue of $3.23M and earned -$14.65M in profits. Earnings per share was $-0.32.
| Revenue | 3.23M |
| Gross Profit | 1.30M |
| Operating Income | -15.58M |
| Net Income | -14.65M |
| EBITDA | -15.25M |
| EBIT | -15.58M |
| Earnings Per Share (EPS) | -0.32 |
Balance Sheet
The company has $10.53M in cash and $599.00K in debt, giving a net cash position of $9.93M.
| Cash & Cash Equivalents | 10.53M |
| Total Debt | 599.00K |
| Net Cash | 9.93M |
| Retained Earnings | -90.06M |
| Total Assets | 15.28M |
| Working Capital | 8.34M |
Cash Flow
In the last 12 months, operating cash flow was -$12.52M and capital expenditures -$480.00K, giving a free cash flow of -$13.00M.
| Operating Cash Flow | -12.52M |
| Capital Expenditures | -480.00K |
| Free Cash Flow | -13.00M |
| FCF Per Share | -0.28 |
Margins
Gross margin is 40.26%, with operating and profit margins of -482.38% and -453.76%.
| Gross Margin | 40.26% |
| Operating Margin | -482.38% |
| Pretax Margin | -453.76% |
| Profit Margin | -453.76% |
| EBITDA Margin | -472.38% |
| EBIT Margin | -482.38% |
| FCF Margin | -402.63% |
Dividends & Yields
ICCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -30.19% |
| FCF Yield | -22.39% |
Analyst Forecast
The average price target for ICCM is $2.7, which is 154.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.7 |
| Price Target Difference | 154.7% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Aug 9, 2021. It was a backward split with a ratio of 1:8.
| Last Split Date | Aug 9, 2021 |
| Split Type | backward |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | -5.48 |
| Piotroski F-Score | 4 |